Newsbot

» Nachrichtenticker öffnen

CORRECTION: First National Bank Alaska announces unaudited results for fourth quarter and full year 2024

ANCHORAGE, Alaska, March 31, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on February 19, 2025, by First National Bank Alaska (OTCQX:FBAK), please note that in the third paragraph, the value of nonperforming loans as of Dec. 31, 2023 should be $4.6 million, rather than $4.7 million as originally issued. In turn, this resulted in changes to several values in the "Total Interest And Loan Fee Income" and "Total Interest Expense" rows, and the "Nonperforming Loans and OREO"...

US Chip Grants In Limbo as Lutnick Pushes for Bigger Investments

Commerce Secretary Howard Lutnick has signaled he could withhold promised Chips Act grants as he pushes for companies in line for federal semiconductor subsidies to substantially expand their US projects, according to eight people familiar with the matter.

Why China Can’t Sort Out Its Property Market Mess

Once one of the country’s biggest growth drivers, China’s property market has been in a downward spiral for five years with no signs of abating. Real estate values continue to plummet, households in financial distress are being forced to sell properties, and apartment developers that have racked up enormous debt on speculative projects are on the brink of collapse.

New Zealand Sees Red Hot Interest After Golden Visa Revamp

New Zealand has revamped its golden visa program and is seeing "really strong" interest from the US and European markets, according to New Zealand Immigration Minister Erica Stanford. She speaks on The Asia Trade about how geopolitical headwinds are driving investors to look for safe havens. (Source: Bloomberg)

POET Technologies Reports Fourth Quarter 2024 Financial Results

Continued progress toward a revenue inflection point based on in-place contracts with industry leaders and partners Continued progress toward a revenue inflection point based on in-place contracts with industry leaders and partners

China Private Factory Gauge Tops Forecasts Despite Trump Tariffs

China’s manufacturing activity improved at the fastest pace in four months, according to a private survey, a surprising show of resilience that will be tested as Donald Trump prepares to raise tariffs further on exports into the US.

Trump Tariffs May Spell Economic Crisis for Japan, Onodera Says

The Trump administration’s tariffs may spell a big economic crisis for Japan, a senior lawmaker in Japan’s ruling party said, adding that the auto tariffs in particular would have huge implications across all regions in Japan.

Should You Buy Tesla Stock Before April 2?

With shares down 35% year to date, many Tesla (NASDAQ: TSLA) investors have decided that Trumps election victory isnt the windfall they expected. The company is reeling from slowing international sales due in part to CEO Elon Musks political involvement in the new administration. Meanwhile, Chinese rivals like BYD have encroached on Teslas market share in several important regions. On April 2, the situation will get even more complicated as the Trump administration reveals wide-ranging tari...

Australia retail sales rise modest 0.2% in February

Australian retail sales rose modestly for a second straight month in February as a long-awaited cut in interest rates combined with slower inflation to boost consumer sentiment and spending power.

BeiGene erhält positive CHMP-Stellungnahme für TEVIMBRA® als Erstlinienbehandlung bei kleinzelligem Lungenkrebs im extensiven Stadium

SAN CARLOS, Kalifornien--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), ein globales Onkologieunternehmen, das beabsichtigt, seinen Namen in BeOne Medicines Ltd. zu ändern, gab heute bekannt, dass der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittel-Agentur eine positive Stellungnahme abgegeben hat, in der die Zulassung von TEVIMBRA® (Tislelizumab) in Kombination mit einer Chemotherapie mit Etoposid und Platin als Erstlinienbehandlung für erwachsene